ProQR Therapeutics Prices IPO At $13.00 Per Share - Quick Facts

(RTTNews) - ProQR Therapeutics announced the pricing of its initial public offering of 7.50 million ordinary shares at an initial public offering price of $13.00 per ordinary share.

In addition, ProQR has granted the underwriters a 30-day option to purchase up to an additional 1.125 million ordinary shares from ProQR at the public offering price, less underwriting discounts and commissions.

After deducting the underwriting discounts and commissions and other estimated offering expenses payable by ProQR, the net proceeds of the initial public offering are expected to be about $88.4 million.

The offering is expected to close on or about September 23, 2014, subject to customary closing conditions.

ProQR's ordinary shares have been approved for listing on the NASDAQ Global Market and are expected to begin trading under the symbol "PRQR" on September 18, 2014.

Leerink Partners and Deutsche Bank Securities are acting as joint book-running managers for the offering. JMP Securities is acting as lead manager, and H.C. Wainwright & Co., LLC is acting as co-manager for the offering.